Posters (Abstracts 264–2239)
Hepatology, ISSN: 0270-9139, Vol: 66, Issue: S1, Page: 149-1185
2017
- 34Citations
- 130Usage
- 96Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations34
- Patent Family Citations23
- Patent Families23
- Citation Indexes11
- CrossRef11
- Usage130
- Abstract Views130
- Captures96
- Readers96
- 93
- Mentions1
- News Mentions1
- News1
Most Recent News
Herbal and dietary supplements are commonly mislabeled
(HealthDay)—Mislabeling of herbal and dietary supplements (HDS) is common, occurring in more than half of products tested, according to a study scheduled for presentation at The Liver Meeting, being held by the American Association for the Study of Liver Diseases from Oct. 20 to 24 in Washington, D.C.
Article Description
Background. Skeletal muscle hyperammonemia occurs in cirrhosis and contributes to sarcopenia or loss of skeletal muscle mass. Skeletal muscle ammonia disposal occurs in the mitochondria by cataplerosis (loss of tricarboxylic acid- TCA- cycle intermediates) of a-ketoglutarate to generate glutamate and glutamine. Skeletal muscle hyperammonemia also results a unique cellular stress response with partitioning of L-leucine into the mitochondria to assist ammonia disposal, potentially promoting anaple- rosis (entry of TCA cycle intermediates) either directly or indirectly. We have previously reported that skeletal muscle hyperammonemia decreases cellular oxygen consumption, lowers tricarboxylic acid cycle intermediates and increases mitochondrial reactive oxygen species in the muscle. We therefore hypothesized that ammonia induced skeletal muscle mitochondrial dysfunction will be reversed by L-leucine supplementation that is sufficient to satisfy the metabolic demand in the mitochondria. Methods. Differentiated C2C12 murine myotubes were treated with 10mM ammonium acetate or vehicle alone and the response to L leucine 5mM was quantified. Cellular oxygen consumption in the basal state and the response to substrates for components of the electron transport chain (pyruvate and malate for complex I; succinate for complex II) were measured using high sensitivity respirometry in intact and permeabilized myotubes. Concentration of TCA cycle intermediates in cell lysates were quantified using isotope ratio mass spectrometry respectively. Mitochondrial reactive oxygen species were measured by flow cytometry using the fluoroprobe, MitoSox®. ATP content was measured by a fluorometric assay. Complementary studies were performed in myotubes grown in leucine deficient medium that were treated with L-leu- cine. All experiments were done in at least 4 biological replicates. Results. Hyperammonemia decreased intact cell and substrate dependent oxygen consumption in myotubes that were reversed by 5mM L-leucine. Increased reactive oxygen species during hyperammonemia was also decreased by L-Leucine Hyperammonemia resulted in a reduction in TCA cycle intermediates and the intermediate ratios at 6 and 24 h that was reversed by L-leucine. Low cellular ATP content and ATP synthesis were also reversed by L-leucine supplementation. L-leucine deficient medium resulted in a depletion of TCA cycle intermediates that was aggravated by hyperammonemia and reversed by L leucine. Conclusions. We demonstrate for the first time that ammonia induced skeletal muscle mitochondrial dysfunction is reversed by L leucine supplementation and restores the anaplerosis/cataplerosis balance.
Bibliographic Details
https://engagedscholarship.csuohio.edu/scichem_facpub/472; https://engagedscholarship.csuohio.edu/scichem_facpub/471
https://journals.lww.com/01515467-201710001-00003; http://dx.doi.org/10.1002/hep.29501; https://engagedscholarship.csuohio.edu/scichem_facpub/472; https://engagedscholarship.csuohio.edu/cgi/viewcontent.cgi?article=1491&context=scichem_facpub; https://engagedscholarship.csuohio.edu/scichem_facpub/471; https://engagedscholarship.csuohio.edu/cgi/viewcontent.cgi?article=1490&context=scichem_facpub; https://dx.doi.org/10.1002/hep.29501; https://journals.lww.com/hep/Citation/2017/10001/Posters__Abstracts_264_2239_.3.aspx; http://doi.wiley.com/10.1002/hep.29501; https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.29501; https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.29501; https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.29501; https://onlinelibrary.wiley.com/doi/full/10.1002/hep.29501; https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29501; http://onlinelibrary.wiley.com/doi/10.1002/hep.29501/full; https://onlinelibrary.wiley.com/doi/abs/10.1002/hep.29501; https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.29501
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know